semaglutide for parkinson's Weight-loss drug does not slow Alzheimer's disease, two clinical trials find Details of failed studies cast

Some people may also experience loss of appetite or constipation

At Mitogenesis, we provide professional guidance, and personalized follow-up to ensure that the treatment is effective and safe

Schizophr Res 172(13):101105 Merritt K, Egerton A, Kempton MJ, Taylor MJ, McGuire PK (2016) Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies

This analysis further assessed whether the increase in DRP was a GLP-1 specific effect, or rather caused by a robust and early glucose lowering as suggested by several other studies, where acute and large reductions in glucose concentrations may initially and transiently worsen DRP, yet prevent or delay onset or progression of DRP in the long term (123128)

But the real-world data tells a different, far more interesting story

References 1 Carmina, E